Long-Term Investments (Details) - Schedule of Long-Term Investment - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Long-Term Investment [Line Items]
Non-marketable Cost Method Investments, net	$ 810,977	$ 847,252
Equity Method Investments, net	2,474,514	2,527,740
Braingenesis Biotechnology Co., Ltd. [Member]
Schedule of Long-Term Investment [Line Items]
Non-marketable Cost Method Investments, net	6,904	7,213
Genepharm Biotech Corporation [Member]
Schedule of Long-Term Investment [Line Items]
Non-marketable Cost Method Investments, net	21,078	22,021
BioHopeKing Corporation [Member]
Schedule of Long-Term Investment [Line Items]
Non-marketable Cost Method Investments, net	782,995	818,018
BioFirst Corporation [Member]
Schedule of Long-Term Investment [Line Items]
Equity Method Investments, net	1,663,537	1,680,488
Rgene Corporation [Member]
Schedule of Long-Term Investment [Line Items]
Equity Method Investments, net